# Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.

> **NCT06590662** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 60 (estimated)

## Conditions studied

- Idiopathic Hypersomnia

## Interventions

- **DRUG:** Solriamfetol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06590662
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-15
- **Primary completion:** 2026-11-15
- **Final completion:** 2027-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06590662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06590662, "Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06590662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*